Boston Scientific Receives FDA Approval of New Clik Anchor for Precision Plus Spinal Cord Stimulator System

Boston Scientific Corporation BSX today announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Clik™ Anchor for its Precision Plus™ Spinal Cord Stimulator (SCS) System, the world's first rechargeable SCS device for chronic pain management. The Clik Anchor features an innovative locking system designed to improve lead anchoring speed and consistency. Locking into place on the lead with a simple turn of a hex wrench, it provides tactile and audible confirmation for physicians that the lead is secured. The Company is introducing the Clik Anchor at the American Academy of Pain Medicine Annual Meeting, which begins today in Washington, D.C.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsFDAHealth CareHealth Care EquipmentIndustrialsOffice Services & Supplies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!